Industry / All Other Basic Organic Chemical Manufacturing
Latest filings
DEFR14A
IFF
International Flavors & Fragrances
1 Apr 24
Revised proxy
5:22pm
ARS
2023 FY
CE
Celanese Corp - Ordinary Shares - Series A
21 Mar 24
Annual report to shareholders
4:54pm
DEFA14A
CE
Celanese Corp - Ordinary Shares - Series A
21 Mar 24
Additional proxy soliciting materials
4:51pm
DEF 14A
CE
Celanese Corp - Ordinary Shares - Series A
21 Mar 24
Definitive proxy
4:47pm
8-K
IFF
International Flavors & Fragrances
21 Mar 24
Departure of Directors or Certain Officers
4:20pm
ARS
2023 FY
IFF
International Flavors & Fragrances
21 Mar 24
Annual report to shareholders
8:37am
DEFA14A
IFF
International Flavors & Fragrances
21 Mar 24
Additional proxy soliciting materials
8:01am
DEF 14A
IFF
International Flavors & Fragrances
21 Mar 24
Definitive proxy
8:01am
8-K
IFF
International Flavors & Fragrances
19 Mar 24
IFF Announces Sale of its Pharma Solutions Business to Roquette
7:04am
144
CE
Celanese Corp - Ordinary Shares - Series A
15 Mar 24
Notice of proposed sale of securities
9:49am
News
RBC Capital Maintains Outperform on Celanese, Raises Price Target to $171
CE
19 Apr 24
How Is The Market Feeling About Celanese?
CE
12 Apr 24
Barclays Maintains Underweight on Intl Flavors & Fragrances, Raises Price Target to $75
IFF
12 Apr 24
Evaluating Intl Flavors & Fragrances: Insights From 14 Financial Analysts
IFF
10 Apr 24
Citigroup Maintains Neutral on Celanese, Raises Price Target to $167
CE
10 Apr 24
Citigroup Upgrades Intl Flavors & Fragrances to Buy, Raises Price Target to $100
IFF
10 Apr 24
A Closer Look at 11 Analyst Recommendations For Celanese
CE
9 Apr 24
Keybanc Maintains Overweight on Celanese, Raises Price Target to $190
CE
9 Apr 24
Barclays Downgrades Celanese to Equal-Weight, Maintains Price Target to $170
CE
4 Apr 24
Wells Fargo Maintains Overweight on Intl Flavors & Fragrances, Raises Price Target to $100
IFF
4 Apr 24
Press releases
Celanese Announces Kim K.W. Rucker as New Lead Independent Director
CE
22 Apr 24
Celanese Corporation Declares Quarterly Dividend of $0.70 Per Share
CE
17 Apr 24
IFF to Release First Quarter 2024 Results on May 6, 2024
IFF
16 Apr 24
Chemical Marketing & Economics Honors Celanese Chairman, CEO and President Lori J. Ryerkerk with STEM Leadership Award for Corporate Reinvention
CE
16 Apr 24
Celanese Completes Series of Strategic Actions Across its Global Acetyl Chain
CE
9 Apr 24
IFF Completes Divestiture of Cosmetics Ingredients Business
IFF
3 Apr 24
IFF Brings Science-Backed Excipients to Asia Pharmaceutical Industry at CPhI Japan 2024
IFF
25 Mar 24
Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense Therapies
CE
20 Mar 24
IFF Launches Advertising Campaign Celebrating The Art Of Perfumery
IFF
4 Mar 24
IFF Announces Grant of Employment Inducement Awards
IFF
1 Mar 24
Community annotations
demand for materials to suppprt electrification
Transcript
2023 Q1
CE
30 Jun 23
auto builds recovery
Transcript
2023 Q1
CE
30 Jun 23
guidance reduction
Transcript
2023 Q1
CE
18 May 23
electrification good, elec cons lagging, packaging ok
Transcript
2023 Q1
CE
18 May 23
construction sluggish
Transcript
2023 Q1
CE
18 May 23
13-14 for 2023
Transcript
2022 Q3
CE
4 Jan 23
disappointed
Transcript
2022 Q3
CE
4 Jan 23
Transcripts
CE
Earnings call transcript
2023 Q4
21 Feb 24
IFF
Earnings call transcript
2023 Q4
21 Feb 24
CE
Earnings call transcript
2023 Q3
7 Nov 23
IFF
Earnings call transcript
2023 Q3
7 Nov 23
IFF
Earnings call transcript
2023 Q2
8 Aug 23
CE
Earnings call transcript
2023 Q2
8 Aug 23
CE
Earnings call transcript
2023 Q1
10 May 23
IFF
Earnings call transcript
2023 Q1
9 May 23
IFF
Earnings call transcript
2023 Q1
9 May 23
CE
Earnings call transcript
2022 Q4
24 Feb 23
Patents
Utility
CAS9 Variants and Methods of Use
IFF
18 Jan 24
Utility
Circular economic methods for fragrance ingredients
IFF
16 Jan 24
Utility
Compositions and methods for increased protein production in bacillus licheniformis
IFF
9 Jan 24
Utility
Megastigmane Derivative Compositions and Methods for Taste Modulation
IFF
4 Jan 24
Utility
Compositions and methods comprising the use of a
IFF
2 Jan 24
Utility
Monolithic Implantable Device for Sustained Release of an Antibody
CE
21 Dec 23
Utility
Combination of Nonmaltogenic Exoamylase and Glucoamylase for Improving Bread Resilience and Reducing Amount of Added Sugars
IFF
21 Dec 23
Utility
Coated Granules Produced by In-situ Crosslinking Process
IFF
21 Dec 23
Utility
Alpha Amylases In Feed
IFF
21 Dec 23
Utility
Enzymatic modification of wheat phospholipids in bakery applications
IFF
19 Dec 23
Reddit threads
I'm a professional trader and this is everything I'm watching and analysing in premarket. 19/03
RBA
FOMC
NVDA
19 Mar 24
So my moms financial advisor did this... genius or wreckless?
NVDA
TSLA
ATI
12 Mar 24
Tuesday March 12, 2024 | My 01:50 PM EST Trade (Consistent Strategy For Me)
CE
12 Mar 24
It’s time WE admit we're entering a new economic/financial paradigm, and the advice that got people ahead in the 1990s to 2020s NO longer applies
CPA
SAP
HR
27 Feb 24
I'm a full time trader and this is everything I'm watching and analysing in premarket 02/21
NVDA
RISE
RBA
21 Feb 24
What went wrong?
MSS
DTE
TA
3 Feb 24
January 31st, 2024 | Update to my strategy with a high probability success rate.
CE
AMD
MSFT
31 Jan 24
Difference in change in permium of CE and PE
CE
14 Jan 24
What's The Penny Stock You're Holding Through 2024?
BMR
ABAT
ATOS
29 Dec 23
Daily Discussion Thread - December 27th, 2023
LIDR
NXU
AAMC
27 Dec 23